What a year for Psychiatry - the scope, ambition and impact of our research continues to blow me away. I am also so impressed and grateful for the commitment so many of you make to helping Psychiatry be a positive and welcoming place to be.
We have delivered some hugely important research this year: the PAX-D trial showed that Parkinson’s drug Pramipexole was effective for difficult-to-treat depression, we identified the likely chemicals in vaccines that reduced the risk of dementia, and we used novel participatory arts methods to understand peoples experience of mental illness and mental health services. We’ve surveyed tens of thousands of children about their mental health; piloted ground-breaking therapies for eating disorders.
Next year, the Department will be the new home of an NIHR Applied Research Collaboration, which in addition to Oxford Health Biomedical Research Centre, is testament to our status as an innovative, effective and world-leading Psychiatry department. Our Oxford Brain Health Clinic marked its five year anniversary having had more than 500 patients through its doors, having made a tangible impact on both research, including through UK Biobank, but also on patients’ lives by offering tests that make dementia diagnoses more accurate.
Read the full story on the Department of Psychiatry website.